Concepedia

Janet D. Kemp

JD

Statistics

Publications

4

Citations

240

H-Index

4

Active since

1980

Affiliations

AstraZeneca (United Kingdom)(Current)

Janet D. Kemp is an author at AstraZeneca (United Kingdom) specializing in medicine, neuroscience, and neuropharmacology.

Top concepts

MedicineNeuroscienceNeuropharmacologyPhysiologyNeuroanatomyPharmacologyNervous SystemHealthNeurochemistryNeurophysiology

Publications per year

1980–1984

4

Publications

4

Characterisation of Inhibitory 5‐Hydroxytryptamine Receptors That Modulate Dopamine Release in the Striatum

Christine Ennis, Janet D. Kemp, Barry Cox · Journal of Neurochemistry · 1981 · 163 citations

Neurotransmitter, Potassium-evoked Tritium Release, Psychopharmacology +20

Evidence that 5-HT agonist-induced rotational behaviour in the rat is mediated via 5-HT1 receptors

Thomas P. Blackburn, Janet D. Kemp, Deborah A. Martin et al. · Psychopharmacology · 1984 · 42 citations

Behavioral Neuroscience, Medicine, Functional Selectivity +10

Unilateral 5,7-dihydroxytryptamine lesions of the dorsal raphe nucleus (DRN) and rat rotational behaviour

Thomas P. Blackburn, George A. Foster, Christopher G. Heapy et al. · European Journal of Pharmacology · 1980 · 25 citations

Health Sciences, Neuroanatomy, Physiology +11

Stereospecificity of behavioural effects of viloxazine in bulbectomized rats does not correlate with its 5-HT-releasing action in vitro

D. T. Greenwood, Janet D. Kemp, Derek N. Middlemiss · Journal of Pharmacy and Pharmacology · 1982 · 10 citations

Neuropsychology, Active Isomers, Psychopharmacology +22

1–4 of 4